These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 31570656)
1. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma. Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656 [TBL] [Abstract][Full Text] [Related]
2. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194 [TBL] [Abstract][Full Text] [Related]
3. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions. Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193 [TBL] [Abstract][Full Text] [Related]
4. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma. Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma. Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746 [TBL] [Abstract][Full Text] [Related]
6. Actionable mutations in canine hemangiosarcoma. Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660 [TBL] [Abstract][Full Text] [Related]
7. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart. Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148 [TBL] [Abstract][Full Text] [Related]
8. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma. Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145 [TBL] [Abstract][Full Text] [Related]
9. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report. Teruyama F; Kuno A; Murata Y; Nakagawa T; Shiba-Ishii A; Yuguchi S; Noguchi M Pathol Int; 2022 Sep; 72(9):457-463. PubMed ID: 35801418 [TBL] [Abstract][Full Text] [Related]
10. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients. Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969 [TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of Renal/Adrenal Angiosarcomas Reveals High Frequency of Recurrent Genetic Alterations. Argani P; Saoud C; Antonescu CR Genes Chromosomes Cancer; 2024 Sep; 63(9):e23268. PubMed ID: 39248552 [TBL] [Abstract][Full Text] [Related]
12. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Beca F; Krings G; Chen YY; Hosfield EM; Vohra P; Sibley RK; Troxell ML; West RB; Allison KH; Bean GR Mod Pathol; 2020 Aug; 33(8):1518-1526. PubMed ID: 32123305 [TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma. Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430 [TBL] [Abstract][Full Text] [Related]
14. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma. Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Italiano A; Chen CL; Thomas R; Breen M; Bonnet F; Sevenet N; Longy M; Maki RG; Coindre JM; Antonescu CR Cancer; 2012 Dec; 118(23):5878-87. PubMed ID: 22648906 [TBL] [Abstract][Full Text] [Related]
16. Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers. Cobleigh MA; Layng KV; Mauer E; Mahon B; Hockenberry AJ; Abukhdeir AM Breast Cancer Res Treat; 2024 Apr; 204(2):407-414. PubMed ID: 38153569 [TBL] [Abstract][Full Text] [Related]
17. Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds. Alsaihati BA; Ho KL; Watson J; Feng Y; Wang T; Dobbin KK; Zhao S Nat Commun; 2021 Aug; 12(1):4670. PubMed ID: 34344882 [TBL] [Abstract][Full Text] [Related]
18. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile. Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404 [TBL] [Abstract][Full Text] [Related]
19. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542 [TBL] [Abstract][Full Text] [Related]
20. Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma. Wan H; Zhang D; Hu W; Xie Z; Du Q; Xia Q; Wen T; Jia H Medicine (Baltimore); 2021 Jul; 100(30):e26779. PubMed ID: 34397726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]